Pasireotide-d7
Isotope labelled Pasireotide. Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor®, which is used in the treatment of Cushing's disease.
Online Inquiry
| CAT# | 10-101-197 |
| CAS | 396091-73-9 (non-labelled) |
| Synonyms/Alias | Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]-d7; SOM 230-d7SOM 320-d7; Signifor-d7; |
| M.F/Formula | C₅₈H₅₉D₇N₁₀O₉ |
| M.W/Mr. | 1054.25 |
| Sequence | Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]-d7 |
| Labeling Target | Somatostatin receptor |
| Application | Pasireotide-d7 is invesgated for the treatment of Cushing's disease, specifically for those patients whom pituitary surgery has not been curative or is not an option. |
| Purity | 98.0 % min |
| Functions | Somatostatin receptor activity |
| CAT# |
Product Name |
M.W |
Molecular Formula |
Inquiry |
| 10-101-169 |
Pasireotide |
1047.20624 |
C58H66N10O9 |
Inquiry |
Write a review
Ask a question
My Review for Pasireotide-d7
Required fields are marked with *
×
Ask a Question for Pasireotide-d7
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
